On February 25, 2025, Health Alliance Medical Plans (“Health Alliance”) and FirstCarolinaCare (“FCC”) shared with you that Carle Health (“Carle”) had decided to cease health plan operations for its Health Alliance and FCC commercial lines of business as of January 1, 2026, while still evaluating its Medicare Advantage line of business.
Always Grateful With spring in full bloom and summer around the corner, we know it’s a particularly busy time of year for you. Please know how deeply grateful we are for all you do for our members and for us. Your hard work, dedication and skills never go unnoticed. Thank you for your incredible partnership.
Effective April 1, 2025, Stelara (ustekinumab) will be a nonformulary medication, and all non-Medicare patients will need to switch to an ustekinumab biosimilar for covered treatment.
Carle Health has announced after careful consideration, as of January 1, 2026, our health plans will cease operating all lines of business except for Medicare Advantage.